SBC logo Authors: Amine Heddad, Andrea Krings, Markus Brameier and Bob MacCallum, Stockholm Bioinformatics Center, Stockholm University, Sweden.

NucPred

Fetching P15989 from www.uniprot.org...

The NucPred score for your sequence is 0.44 (see score help below)

   1  MRKHRHLPLAAILGLLLSGFCSVGAQQQAAVRNVAVADIIFLVDSSWSIG    50
51 KEHFQLVREFLYDVVKALDVGGNDFRFALVQFSGNPHTEFQLNTYPSNQD 100
101 VLSHIANMPYMGGGSKTGKGLEYLIENHLTKAAGSRASEGVPQVIIVLTD 150
151 GQSQDDVALPSSVLKSAHVNMIAVGVQDAVEGELKEIASRPFDTHLFNLE 200
201 NFTALHGIVGDLVASVRTSMTPEQAGAKGLVKDITAQESADLIFLIDGSD 250
251 NIGSVNFQAIRDFLVNLIESLRVGAQQIHIGVVQYSDQPRTEFALNSYST 300
301 KADVLDAVKALSFRGGKEANTGAALEYVVENLFTQAGGSRIEEAVPQILV 350
351 LISGGESSDDIREGLLAVKQASIFSFSIGVLNADSAELQQIATDGSFAFT 400
401 ALDIRNLAALRELLLPNIVGVAQRLILLEAPTIVTEVIEVNKKDIVFLID 450
451 GSTALGTGPFNSIRDFVAKIVQRLEVGPDLIQVAVAQYADTVRPEFYFNT 500
501 HQNRKDVMANVKKMKLMGGTALNTGSALDFVRNNFFTSAAGCRMEEGVLP 550
551 MLVLITGGKSMDAVEQAAAEMKRNRIVILAVGSRNADVAELQEIAHERDF 600
601 VFQPNDFRLQFMQAILPEVLSPIRTLSGGMVIHETPSVQVTKRDIIFLLD 650
651 GSLNVGNANFPFVRDFVVTLVNYLDVGTDKIRVGLVQFSDTPKTEFSLYS 700
701 YQTKSDIIQRLGQLRPKGGSVLNTGSALNFVLSNHFTEAGGSRINEQVPQ 750
751 VLVLVTAGRSAVPFLQVSNDLARAGVLTFAVGVRNADKAELEQIAFNPKM 800
801 VYFMDDFSDLTTLPQELKKPITTIVSGGVEEVPLAPTESKKDILFLIDGS 850
851 ANLLGSFPAVRDFIHKVISDLNVGPDATRVAVAQFSDNIQIEFDFAELPS 900
901 KQDMLLKVKRMRLKTGKQLNIGVALDEVMRRLFVKEAGSRIEEGIPQFLV 950
951 LLAAGRSTDEVERPSGALKEAGVVTFAIKAKNADLSELERIAYAPQFILN 1000
1001 VESLPRISELQANIVNLLKTIQFQPTVVERGEKKDVVFLIDGSDGVRRGF 1050
1051 PLLKTFVERVVESLDIGRDKVRVAIVQYSNAIQPEFLLDAYEDKADLVSA 1100
1101 IQALTIMGGSPLNTGAALDYLIKNVFTVSSGSRIAEGVPQFLILLTADRS 1150
1151 QDDVRRPSVVLKTSGTVPFGIGIGNADLTELQTISFLPDFAISVPDFSQL 1200
1201 DSVQQAVSNRVIRLTKKEIESLAPDLVFTSPSPVGVKRDVVFLVDGSRYA 1250
1251 AQEFYLIRDLIERIVNNLDVGFDTTRISVVQFSEHPHVEFLLNAHSTKDE 1300
1301 VQGAVRRLRPRGGQQVNVGEALEFVAKTIFTRPSGSRIEEGVPQFLVILS 1350
1351 SRKSDDDLEFPSVQVKQVGVAPMVIAKNMDPEEMVQISLSPDYVFQVSSF 1400
1401 QELPSLEQKLLAPIETLTADQIRQLLGDVTTIPDVSGEEKDVVFLIDSSD 1450
1451 SVRSDGLAHIRDFISRIVQQLDVGPNKVRIGVVQFSNNVFPEFYLRTHKS 1500
1501 KNAVLQAIRRLRLRGGYPVNAGKALDYVVKNYFIKSAGSRIEDGVPQHLV 1550
1551 VILGDQSQDDVNRPANVISSTSIQPLGVGARNVDRNQLQVITNDPGRVLV 1600
1601 VQDFTGLPTLERKVQNILEELTVPTTEGPVYPGPEGKKQADIVFLLDGSI 1650
1651 NLGRDNFQEVLQFVYSIVDAIYEDGDSIQVGLAQYNSDVTDEFFLKDYSS 1700
1701 KPEILDAINKVIYKGGRVANTGAAIKHLQAKHFVKEAGSRIDQRVPQIAF 1750
1751 IITGGKSSDDGQGASMEVAQKGVKVFAVGVRNIDLEEVSKLASESATSFR 1800
1801 VSTAQELSELNEQVLVTLAAAMKEKLCPGTTDVTRDCDLDVILGFDVSDV 1850
1851 GAGQNIFNSQRGLESRVEAVLNRITQMQKISCTGSRAPSVRVAIMAQSRG 1900
1901 GPVEGLDFSEYQPELFERFQGMRTRGPYFLTAETLKSYQNKFRSAPSGST 1950
1951 KVVIHFTDGTDDYLDQMKTASADLRRQGVHALLFVGLDRVKNFEEVMQLE 2000
2001 FGRGFTYNRPLRVNLLDLDFELAEQLDNIAERTCCGVPCKCSGQRGDRGL 2050
2051 PGPIGPKGATGEIGYGGYPGDEGGPGERGPPGVNGTQGFQGCPGHRGTKG 2100
2101 SRGFPGEKGELGEMGLDGIDGEEGDKGLPGFSGEKGFSGRRGSKGAKGER 2150
2151 GERGDRGLRGDPGESGADNTQRGTRGQKGEIGQMGEPGPAGQRGQDGGVG 2200
2201 RKGMAGRRGPIGVKGTKGALGQPGPAGEQGMRGPQGPPGQIGTPGIRGEQ 2250
2251 GIPGPRAGGGQPGAPGERGRIGPLGRKGEPGNPGPRGPNGQQGPRGEMGD 2300
2301 DGRDGIGGPGPKGRKGERGFVGYPGPKGGPGDRGGAGGPGPKGNRGRRGN 2350
2351 AGNPGTPGQKGEIGYPGPSGLKGDKGPSISQCALVQNIKDKCPCCYGPKE 2400
2401 CPVFPTELAFAIDTSSGVGRDVFNRMKQTVLRVVSNLTIAESNCPRGARV 2450
2451 ALVTYNNEVTTEIRFADARKKSSLLQQIQNFQATLTTKPRSLETAMSFVA 2500
2501 RNTFKRARSGFLMRKVAVFFSNGETRASPQLNDAVLKLYDAGVTPVFLTS 2550
2551 RQDAVLERALEINNTAVGHAIVLPTSGSQLNDTIRRLLTCHVCLDVCEPD 2600
2601 PICGYGSQRPVFRDRRAAPTDVDTDIAFIMDSSASTTPLQFNEMKKYISH 2650
2651 LVSNMEISSEPKISQHHARVAVLQQAPYDHETNSSFPPVKTEFSLTDYGS 2700
2701 KEKIINYLHNQMTQLYGTMAMGSAVEHTVAHVFESAPNPRDLKVIVLMIT 2750
2751 GKMEKQELEYLREAVIDAKCKGYLFVILGIGKNVDVKNIYSLASEPNDVF 2800
2801 FKLVSKPGELHEEPLLRFGRLLPSFIRSDFAFYLSPEIRKQCKWLQADQT 2850
2851 PKSPGHTGQKAVYIAPNGTVTQTISTTTTLSTTFKPAASTSAHAKTTTAS 2900
2901 TTAQTRATERPTESTTVQVNATVQSQGSTAANTKATSRTTTSTTAAAASG 2950
2951 RRRQGAKMNDIQITDVTENSARLRWASPEPHNAYVFDLAITLAHDHSLVL 3000
3001 KQNVTGTERVIGGLRSGQKYLVFITGYLKSQPKVTYTGTFSTKTPAQPKV 3050
3051 ALANMMLNAEPLEGPENVMDICLLQKEEGTCRDFVLKWHYDLKTKSCARF 3100
3101 WYGGCGGNENRFNTQKECEKACSPGNISPGVVTTIGT 3137

Positively and negatively influencing subsequences are coloured according to the following scale:

(non-nuclear) negative ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| positive (nuclear)

with NucPred



If you find NucPred useful, please cite this paper:
NucPred - Predicting Nuclear Localization of Proteins. Brameier M, Krings A, Maccallum RM. Bioinformatics, 2007. PubMed id: 17332022
The authors also look forward to your comments and suggestions.

What does the NucPred score mean?

You have to decide on a NucPred score threshold. Sequences which score greater than or equal to this threshold are predicted to spend some time in the nucleus. Higher thresholds yield fewer predicted nuclear proteins, but these predictions are more accurate (you can have higher confidence in them). The table below gives more details of the performance of NucPred estimated using the sequences it was trained on (by cross-validation). Another benchmark is available in the Bioinformatics 2007 paper.

NucPred score threshold Specificity Sensitivity
see above fraction of proteins predicted to be nuclear that actually are nuclear fraction of true nuclear proteins that are predicted (coverage)
0.10 0.45 0.88
0.20 0.52 0.83
0.30 0.57 0.77
0.40 0.63 0.69
0.50 0.70 0.62
0.60 0.71 0.53
0.70 0.81 0.44
0.80 0.84 0.32
0.90 0.88 0.21
1.00 1.00 0.02

Sequences which score >= 0.8 with NucPred and which are predicted by PredictNLS to contain an NLS have been shown to be 93% correct with a coverage of 16%. (PredictNLS by itself is 87% correct with 26% coverage on the same data.)

Go back to the NucPred Home Page.